Testing effectiveness (Phase 2)Ended earlyNCT03352557What this trial is testingPhase 2 Study of BIIB092 in Participants With Early Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Biogen 654
Early research (Phase 1)Study completedNCT04711486What this trial is testingEvaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's DiseaseWho this might be right forMild Cognitive Impairment Due to Alzheimer's Disease Charite University, Berlin, Germany 19
Testing effectiveness (Phase 2)UnknownNCT04141150What this trial is testingEvaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy SubjectsWho this might be right forAlzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers APRINOIA Therapeutics, LLC 130
Not applicableUnknownNCT04012346What this trial is testingModulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's DiseaseWho this might be right forMild Cognitive Impairment Masaryk University 20
Early research (Phase 1)Study completedNCT04931459What this trial is testingEvaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild ADWho this might be right forAlzheimer Disease Acumen Pharmaceuticals 65
Early research (Phase 1)Study completedNCT05681819What this trial is testingSHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Shanghai Hengrui Pharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06182085What this trial is testingStudy to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)Who this might be right forMild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset PRInnovation GmbH 304
Early research (Phase 1)Ended earlyNCT02614131What this trial is testingLY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)Who this might be right forHealthyAlzheimer's DiseaseMild Cognitive Impairment Eli Lilly and Company 50
Testing effectiveness (Phase 2)Study completedNCT02423200What this trial is testingClinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild ADWho this might be right forAlzheimer's Disease EIP Pharma Inc 16
Very early researchActive Not RecruitingNCT04075435What this trial is testingCannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's DementiaWho this might be right forAlzheimer DiseaseAnxietyAgitation,Psychomotor+1 more Mclean Hospital 12
Testing effectiveness (Phase 2)WithdrawnNCT05986721What this trial is testingClinical Trial of AGB101 for Mild Cognitive ImpairmentWho this might be right forMild Cognitive ImpairmentProdromal Alzheimer's Disease AgeneBio
Early research (Phase 1)Not Yet RecruitingNCT07489599What this trial is testingQLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseWho this might be right forAlzheimer's Disease(AD)Mild Cognitive Impairment (MCI) Qilu Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT02702817What this trial is testingRandomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's DementiaWho this might be right forAlzheimer DiseaseCognitive Decline Due to Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer Disease Douglas Mental Health University Institute 200
Not applicableLooking for participantsNCT07089303What this trial is testingAlzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)Who this might be right forAlzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease Chinese PLA General Hospital 750
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612150What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's DiseaseWho this might be right forAlzheimer Disease Merry Life Biomedical Co., Ltd. 210
Early research (Phase 1)Study completedNCT02624778What this trial is testingLY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADWho this might be right forAlzheimer Disease Eli Lilly and Company 61
Not applicableUnknownNCT05732519What this trial is testingTurkish Speech Analysis Development StudyWho this might be right forAlzheimer DiseaseMild Cognitive Impairment mihrimah ozturk 180
Not applicableStudy completedNCT05504811What this trial is testingFitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's DiseaseWho this might be right forCognitive DysfunctionDementia, Mild Flint Rehabilitation Devices, LLC 31
Testing effectiveness (Phase 2)Study completedNCT05104463What this trial is testingCST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's DiseaseWho this might be right forMild Cognitive ImpairmentDementia CuraSen Therapeutics, Inc. 64
Testing effectiveness (Phase 2)Looking for participantsNCT06850597What this trial is testingEfficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's DiseaseWho this might be right forMCIMCI-AD, Early Stage Alzheimer's DiseaseAlzheimer's Disease Medical University of Lodz 30